Literature DB >> 17172646

Immune response and immunotherapy to Cryptococcus infections.

Qing Zhou1, William J Murphy.   

Abstract

Cryptococcus neoformans is a ubiquitous fungus that can cause lifethreatening infections during immunosuppressive states such as acquired immunodeficiency syndrome (AIDS) and after bone marrow transplantation (BMT). Infected individuals normally succumb to meningitis and meningoencephalitis caused by dissemination of C. neoformans to the brain. In this review, we analyze the current understanding of the interaction between host immune response and C. neoformans as well as the current state of immunotherapeutic strategies for treating cryptococcosis.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17172646     DOI： 10.1385/IR:35:3:191

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


  151 in total

1.  Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.

Authors:  A Vecchiarelli; C Retini; C Monari; C Tascini; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.

Authors:  N Mozaffarian; J W Berman; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin.

Authors:  M Steinbakk; C F Naess-Andresen; E Lingaas; I Dale; P Brandtzaeg; M K Fagerhol
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

4.  Involvement of endogenously synthesized interleukin (IL)-18 in the protective effects of IL-12 against pulmonary infection with Cryptococcus neoformans in mice.

Authors:  K Kawakami; M H Qureshi; T Zhang; Y Koguchi; S Yara; K Takeda; S Akira; M Kurimoto; A Saito
Journal:  FEMS Immunol Med Microbiol       Date:  2000-03

5.  Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.

Authors:  Donatella Pietrella; Cristina Corbucci; Stefano Perito; Giovanni Bistoni; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 6.  Intracellular parasitism of macrophages by Cryptococcus neoformans.

Authors:  M Feldmesser; S Tucker; A Casadevall
Journal:  Trends Microbiol       Date:  2001-06       Impact factor: 17.079

7.  Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes.

Authors:  S M Levitz; E A North; M P Dupont; T S Harrison
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response.

Authors:  Sean K Bauman; Gary B Huffnagle; Juneann W Murphy
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  MHC class II-positive perivascular microglial cells mediate resistance to Cryptococcus neoformans brain infection.

Authors:  Karen Aguirre; Shannon Miller
Journal:  Glia       Date:  2002-08       Impact factor: 7.452

10.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808
View more
  3 in total

1.  Cryptococcosis associated with crescentic glomerulonephritis.

Authors:  Marta Suárez-Rivera; Rania A Abadeer; Marylee M Kott; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2008-02-06       Impact factor: 3.714

2.  CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.

Authors:  Jeremy Day; Darma Imran; Ahmed Rizal Ganiem; Natriana Tjahjani; Retno Wahyuningsih; Robiatul Adawiyah; David Dance; Mayfong Mayxay; Paul Newton; Rattanaphone Phetsouvanh; Sayaphet Rattanavong; Adrienne K Chan; Robert Heyderman; Joep J van Oosterhout; Wirongrong Chierakul; Nick Day; Anatoli Kamali; Freddie Kibengo; Eugene Ruzagira; Alastair Gray; David G Lalloo; Justin Beardsley; Tran Quang Binh; Tran Thi Hong Chau; Nguyen Van Vinh Chau; Ngo Thi Kim Cuc; Jeremy Farrar; Tran Tinh Hien; Nguyen Van Kinh; Laura Merson; Lan Phuong; Loc Truong Tho; Pham Thanh Thuy; Guy Thwaites; Heiman Wertheim; Marcel Wolbers
Journal:  Trials       Date:  2014-11-12       Impact factor: 2.279

3.  Central Nervous System Vasculitis for Cryptococcosis in an Immunocompetent Patient.

Authors:  Dan Zimelewicz Oberman; Liliana Patrucco; Carolina Cuello Oderiz
Journal:  Diseases       Date:  2018-08-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.